Clinical Trials

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT03601442 2026-04-23

Managed Access Programs for CTL019, Tisagenlecleucel

Available

Leukemia, Lymphoma

NCT04094311 2026-04-20

Study of Out of Specification for Tisagenlecleucel

Phase 3 Recruiting

200 enrolled

Phase 3 Active not recruiting

Burkitt Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05888493 2026-04-17

LEDA

109 enrolled

Lymphoma, Follicular, Recurrence

NCT05075603 2025-10-23

Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Phase 1 Completed

17 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03568461 2025-10-07

ELARA

98 enrolled 9 charts 1 FDA

Lymphoma, Follicular, Recurrence

NCT05541341 2025-06-06

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

Recruiting

200 enrolled

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03610724 2024-06-20

BIANCA

34 enrolled 19 charts

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02445248 2024-04-18

JULIET

115 enrolled 22 charts 1 FDA

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02435849 2024-02-13

ELIANA

80 enrolled 39 charts

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04156659 2023-03-09

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Phase 2 Withdrawn

Burkitt Lymphoma

NCT03876028 2023-01-31

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Phase 1 Terminated

10 enrolled

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04225676 2023-01-30

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2 Terminated

5 enrolled 8 charts

Burkitt Lymphoma, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05541328 2022-09-15

Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Completed

169 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03630159 2022-08-15

PORTIA

Phase 1 Completed

12 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05349201 2022-07-01

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

Completed

273 enrolled

Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04456023 2022-03-02

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Phase 2 Withdrawn

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03123939 2021-07-21

Phase III B in Acute Lymphoblastic Leukemia

Phase 3 Completed

69 enrolled 26 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02228096 2020-11-23

ENSIGN

75 enrolled 41 charts

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03628053 2020-07-09

OBERON

Phase 3 Withdrawn